BioengineeringbioRxivPreprint
Patient-Centric Development of a Low-Volume, Low-Viscosity, Once Every 4 Weeks (Q4W) Autoinjector Combination Product for Povetacicept
Joanie Lucas, J Alaina Floyd, Erin Hickey…·Gabriel C. Graffius
This paper describes the development of a low-volume, low-viscosity, once-every-4-weeks autoinjector for povetacicept, focusing on improving patient experience through formulation and device integration.
DOI 10.64898/2026.10.20.760382